Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in Japan
Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in Japan
复制标题
社区药剂师确保安全使用口服抗癌药物的能力评估：日本全国范围内的调查
DOI：
10.1093/jjco/hyx015
复制
发表时间：
2017
影响因子：
2.4
通讯作者：
K. Endo
中科院分区：
文献类型：
--
作者：
Shinya Suzuki;Rick Abbott;H. Sakurai;K. Kawasumi;Philip E. Johnson;M. Tahara;M. Yamaguchi;S. Saito;G. Yee;K. Endo
目标
Objectives
A recent study of community pharmacists in Canada reported that they required additional education. We conducted a survey of community pharmacists to evaluate the adequacy of education and training in oral anticancer agents in Japan.
Methods
Between May and June 2014, community pharmacists were asked to complete a questionnaire by using two different survey strategies, one online and one via postal mail.
Results
Three hundred community pharmacists responded to an online survey and 283 community pharmacists responded to a mailed survey. Only 6-10% of respondents felt that they had received adequate education in oncology or oral chemotherapy. Although 81% of Japanese pharmacists had attended at least one continuing education event related to oncology in the past 2 years, only 54% felt comfortable dispensing oral anticancer agents and only 40% felt comfortable educating patients about oral chemotherapy. In a multivariate analysis, confidence in educating patients about oral chemotherapy was associated with an understanding of chemotherapy cycles and doses (odds ratio = 4.89, 95% confidence interval [2.53-9.45]) and the number of continuing education events they had attended (odds ratio = 1.67, 95% confidence interval [1.35-2.08]).
Conclusions
This is the first report to evaluate whether community pharmacists are equipped to ensure the safe use of oral anticancer agents in Japan. The results are similar to those previously reported for Canadian pharmacists, namely a low rate of positive responses for education in oncology and oral chemotherapy, demonstrating a similar need for additional education and training in oral chemotherapy.